Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multiple sclerosis treatment effects on plasma cytokine receptor levels.

Clinical immunology (Orlando, Fla.) - 1 Feb 2018

Bedri Sahl Khalid, Fink Katharina, Manouchehrinia Ali, Lundström Wangko, Kockum Ingrid, Olsson Tomas, Hillert Jan, Glaser Anna

Abstract excerpt

Genetic variants within some cytokine receptor genes have been associated with MS susceptibility, including IL7RA and IL2RA. As these genes are expressed by cells targeted by immune-modulatory drugs, we explored the potential role of their gene products as biomarkers in monitoring MS treatment. We assessed the impact of natalizumab followed by fingolimod on the intra-individual changes of plasma protein levels of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytokine Receptor gp130
Share to Immunologic Factors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunosuppressive Agents

Share to Interleukin-2 Receptor alpha Subunit

Share to Interleukin-7 Receptor alpha Subunit

Share to Multiple Sclerosis

Share to Pharmacogenomic Testing

Share to Young Adult

Source

Identifiers

PMID: 28941836
DOI: 10.1016/j.clim.2017.08.023

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multiple sclerosis treatment effects on plasma cytokine receptor levels.PMID 28941836Read ↗

Decreased systemic IL-7 and soluble IL-7Rα in multiple sclerosis patients.Semantic proximity Read ↗

Soluble IL-2RA levels in multiple sclerosis subjects and the effect of soluble IL-2RA on immune responses.Semantic proximity Read ↗

IL7RA haplotype-associated alterations in cellular immune function and gene expression patterns in multiple sclerosis.Semantic proximity Read ↗

Interleukin 7 Receptor Alpha Gene Variants Are Correlated with Gene Expression in Patients with Relapsing-remitting Multiple Sclerosis.Semantic proximity Read ↗

Variation in the IL7RA and IL2RA genes in German multiple sclerosis patients.Semantic proximity Read ↗

IL2RA Methylation and Gene Expression in Relation to the Multiple Sclerosis-Associated Gene Variant rs2104286 and Soluble IL-2Rα in CD8+ T Cells.Semantic proximity Read ↗

Investigation of the role of antagonism of the Interleukin-7 Receptor in the treatment of Multiple Sclerosis in humans and in vitro differences between genetically stratified subjects based on Interleukin-7 receptor genotypeSemantic proximity Read ↗

Association between IL7 Receptor Alpha (Il7ra) gene rs6897932 polymorphism and the risk of Multiple Sclerosis: A meta-regression and meta-analysis.Semantic proximity Read ↗

Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis.Semantic proximity Read ↗

The IL-7Rα pathway is quantitatively and functionally altered in CD8 T cells in multiple sclerosis.Semantic proximity Read ↗

Interleukin 7 receptor polymorphisms and the risk of multiple sclerosis: A meta-analysis.Semantic proximity Read ↗

Biomarkers of systemic inflammation, soluble IL-2Rα and the multiple sclerosis-associated IL2RA SNP rs2104286 in healthy subjects and multiple sclerosis patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.